Saurav Verma(@SauraVermaMD) 's Twitter Profile Photo

Sharing our review article on Management of Resectable Stage III NSCLC in the Era of Neoadjuvant Immunotherapy. We discuss the evidence and unanswered questions in this space. mdpi.com/2729712 Dr. Daniel Breadner Jacques Raphael Abhenil Mittal Dr. David Palma

Sharing our review article on Management of Resectable Stage III NSCLC in the Era of Neoadjuvant Immunotherapy. We discuss the evidence and unanswered questions in this space. mdpi.com/2729712 #mdpicancers #lcsm @DrDanBreadner @JackRaph @abhenilmittal @drdavidpalma
account_circle
Benlazar S M A(@smbenlazar) 's Twitter Profile Photo

Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study mdpi.com/2728180 via Cancers MDPI

Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study mdpi.com/2728180 #mdpicancers via @Cancers_MDPI #lymsm
account_circle
José Azevedo(@JGMAzevedo) 's Twitter Profile Photo

Textbook Oncological Outcomes for Robotic Colorectal Cancer Resections: An Observational Study of Five Robotic Colorectal Units

How to measure/inform the ideal surgical practice?

mdpi.com/2403716

via Cancers MDPI

Textbook Oncological Outcomes for Robotic Colorectal Cancer Resections: An Observational Study of Five Robotic Colorectal Units 

How to measure/inform the ideal surgical practice?

mdpi.com/2403716

#mdpicancers via @Cancers_MDPI
account_circle
PDBrown(@PDBrownOnc) 's Twitter Profile Photo

CNS SFT week 7/7
Are there low risk SFT that can be observed after surgery?
· Possibly yes
· 2 large national datasets
· 3 risk categories
mdpi.com/2104952 via Cancers MDPI

CNS SFT week 7/7
Are there low risk SFT that can be observed after surgery?
· Possibly yes
· 2 large national datasets
· 3 risk categories 
mdpi.com/2104952 #mdpicancers via @Cancers_MDPI
account_circle
Hapangama Research Group(@Hapangama_Lab) 's Twitter Profile Photo

Surgical Treatment for Endometrial Cancer, Hysterectomy Performed via Minimally Invasive Routes Compared with Open Surgery: A Systematic Review and Network Meta-Analysis mdpi.com/2787176 via Cancers MDPI

account_circle
Benlazar S M A(@smbenlazar) 's Twitter Profile Photo

Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma mdpi.com/2617052 via Cancers MDPI

Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma mdpi.com/2617052 #mdpicancers via @Cancers_MDPI  #lymsm
account_circle
Saeid Ghavami(@CellAutophagy) 's Twitter Profile Photo

Happy to share our recent comprehensive review on Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches mdpi.com/2546586 via Cancers MDPI targeting autophagy UPR and apoptosis. It includes all recent pharmacological intervention and models

Happy to share our recent comprehensive review on Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches mdpi.com/2546586 #mdpicancers via @Cancers_MDPI targeting autophagy UPR and apoptosis. It includes all recent pharmacological intervention and models
account_circle
Georgios Pongas, MD(@pongasg) 's Twitter Profile Photo

Extremely proud of our Miller Medicine Sylvester Comprehensive Cancer Center Hematology Fellows Ali Al Sbihi, MD and @MariamBird for publishing our review manuscript describing the latest advances of ADC in lymphoid malignancies mdpi.com/2682010 via Cancers MDPI

account_circle
Salvador Pedraza(@salvasapedraza) 's Twitter Profile Photo

Prognostic Value of Baseline 18F-FDG PET/CT to Predict Brain Metastasis Development in Melanoma Patients mdpi.com/2615896 a través de Cancers MDPI

Prognostic Value of Baseline 18F-FDG PET/CT to Predict Brain Metastasis Development in Melanoma Patients mdpi.com/2615896 #mdpicancers a través de @Cancers_MDPI
account_circle
Roberto Iacovelli(@DrIacovelli) 's Twitter Profile Photo

🎉Finally out this extensive review about the role of the Complement in Clear Cell Renal Carcinoma (ccRCC) Special thanks to Martina Panebianco Chiara and all coauthors. mdpi.com/2650168 via Cancers MDPI OncoDaily Kidney Cancer KidneyCAN UroToday.com

🎉Finally out this extensive review about the role of the Complement in Clear Cell Renal Carcinoma (ccRCC) Special thanks to @MartiPanebianco @ciccarese_c and all coauthors. mdpi.com/2650168 #mdpicancers via @Cancers_MDPI @oncodaily @KidneyCancer @kidneycan @urotoday
account_circle